Product Details
Tehran Chemie Achora Tetrabenazine 25mg In Pakistan
Achora 25mg contains tetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor. Tetrabenazine is used to reduce involuntary movements (chorea) associated with Huntington’s disease. Achora 25mg is manufactured by Tehran Chemie.
Tetrabenazine is a prescription neurological medicine and its dose must be individually adjusted according to the patient's condition and response to treatment.
Benefits
- Helps reduce involuntary movements associated with Huntington’s disease.
- Acts on the VMAT2 system to decrease the release of certain neurotransmitters involved in abnormal movements.
- May help improve control of chorea when appropriately prescribed.
- Available as an oral 25mg tablet.
- The tablet formulation allows individualized dose adjustment under medical supervision.
Specifications
| Specification | Details |
|---|---|
| Brand | Achora |
| Manufacturer | Tehran Chemie |
| Active Ingredient | Tetrabenazine |
| Strength | 25mg |
| Dosage Form | Tablet |
| Drug Class | VMAT2 Inhibitor |
| Main Indication | Chorea associated with Huntington’s disease |
| Route | Oral |
| Prescription | Required |
How To Use
- Take Achora exactly as prescribed by your neurologist.
- Tetrabenazine treatment requires gradual dose titration to identify the dose that controls symptoms while remaining tolerable.
- In the U.S. prescribing information, the initial dose is 12.5mg once daily, increasing to 25mg/day after one week; subsequent increases are made gradually according to response and tolerability.
- Tetrabenazine may be taken with or without food.
- Do not change the dose, stop treatment, or restart treatment after an extended interruption without medical advice.
- Patients taking strong CYP2D6 inhibitors or requiring higher doses may need specific dose restrictions or CYP2D6 testing.
